---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-047368"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2024-04-15T23:59:59+00:00"
generated_at: "2026-06-03T22:57:23.134839+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals increases ATM offering to $4.85M after $1M already sold

## Summary
- Maximum aggregate offering price raised to $4,852,909 under existing August 2023 ATM agreement with H.C. Wainwright.
- Prior to this filing, $1.0 million in common stock had been sold under the same agreement.
- Prospectus supplement filed April 15, 2024 to register the additional shares.
- No specific use of proceeds disclosed in the filing.

## SEC filing metadata
- accession: 0001104659-24-047368
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2024-04-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000110465924047368/0001104659-24-047368-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000110465924047368/tm2411778d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-047368
- JSON: https://secwatch.observer/filing/0001104659-24-047368.json
- Plain text: https://secwatch.observer/filing/0001104659-24-047368.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.